J R Keller

Statistics

Publications

Citations

1.2K

H-Index

Active since

1985

Affiliations

Frederick National Laboratory for Cancer Research(Current)

National Cancer Institute

Genesis Laboratories

LabCorp (United States)

Science Applications International Corporation (United States)

J R Keller is an author at Frederick National Laboratory for Cancer Research specializing in life sciences, bone marrow - derived cells, and cell biology.

Publications per year

1985–1998

Publications

Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells

Kjetil Hestdal, F W Ruscetti, James N. Ihle et al. · The Journal of Immunology · 1991 · 485 citations

Life Sciences, Cell Biology, Immunology +11

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines.

J R Keller, Charlie Mantel, Garwin Sing et al. · The Journal of Experimental Medicine · 1988 · 212 citations · Full text

Life Sciences, Developmental Biology, Hematology +17

Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.

J R Keller, Sten Eirik W. Jacobsen, K T Sill et al. · Proceedings of the National Academy of Sciences · 1991 · 109 citations

Life Sciences, Cell Biology, Hematology +15

Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-<i>beta</i> 1.

H Goey, J R Keller, Timothy Back et al. · The Journal of Immunology · 1989 · 102 citations

Life Sciences, Cell Biology, Hematology +12

Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.

Krzysztof Grzegorzewski, F W Ruscetti, N Usui et al. · The Journal of Experimental Medicine · 1994 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 15